Valuation Picture: Discount to Industry Despite Large Cap Status
At a market capitalisation of ₹1,26,056.01 crores, Apollo Hospitals Enterprise Ltd. stands as a large-cap leader in the hospital sector. Its P/E ratio of 60.26 is below the sector average of 67.22, indicating a valuation discount of roughly 10%. This is particularly interesting given the company’s strong historical performance and market position. The discount may reflect investor caution amid recent short-term volatility or a recalibration of growth expectations within the sector. Apollo Hospitals’s valuation premium has narrowed compared to previous years, suggesting a more measured market view despite its robust fundamentals — previously rated Buy, what is Apollo Hospitals’ current rating?
Performance Across Timeframes: Strong Long-Term Gains with Recent Mixed Signals
The stock’s performance over the past decade has been exceptional, delivering a total return of 528.77%, significantly outperforming the Sensex’s 174.73% over the same period. Over five years, the stock gained 83.15%, more than double the Sensex’s 38.66%, and over three years, it returned 81.07% versus the Sensex’s 18.76%. These figures underscore the company’s consistent growth trajectory and resilience in the healthcare sector.
However, the short-term momentum reveals a more complex story. The stock has declined by 0.58% today, underperforming the Sensex’s marginal fall of 0.13%, and has been on a three-day losing streak with a cumulative fall of 1.94%. Over the past month, the stock is down 0.61%, slightly better than the Sensex’s 1.30% decline, but the one-week return of 2.36% outpaces the Sensex’s negative 1.07%. The 3-month return of 9.23% is strong relative to the Sensex’s 2.57%, indicating that while short-term fluctuations exist, the medium-term trend remains positive — is this a recovery or a dead-cat bounce?
Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.
- - Investment Committee approved
- - 50+ candidates screened
- - Strong post-announcement performance
Moving Average Configuration: Mixed Technical Signals
The technical picture for Apollo Hospitals Enterprise Ltd. is characterised by a nuanced moving average (MA) configuration. The stock price currently trades above its 5-day, 50-day, 100-day, and 200-day moving averages, signalling underlying strength and support at these levels. However, it remains below the 20-day moving average, indicating some short-term resistance and potential consolidation. This pattern suggests a recent bounce within a broader trend, where short-term momentum is lagging behind longer-term strength — is this a genuine recovery or a relief rally that will fade at the 50 DMA?
Sector Performance Context: Hospital Industry Trends
The hospital sector has experienced mixed results recently, with a combination of positive, flat, and negative performances across constituent stocks. Against this backdrop, Apollo Hospitals’s relative outperformance over multiple timeframes stands out. The sector’s average P/E of 67.22 reflects elevated valuations, driven by growth expectations in healthcare services. Apollo Hospitals’s valuation discount may be signalling a cautious stance by investors amid sector-wide uncertainties, including regulatory changes and competitive pressures.
Rating Reassessment: Previously Rated Buy
On 14 Aug 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from Buy, reflecting a reassessment of its valuation and performance metrics. The company holds a Mojo Score of 84.0, indicating strong fundamentals and technicals. This reassessment takes into account the valuation premium compression, recent price action, and sector dynamics. Should investors in Apollo Hospitals hold, buy more, or reconsider?
Want to dive deeper on Apollo Hospitals Enterprise Ltd.? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- - Real-time research report
- - Complete fundamental analysis
- - Peer comparison included
Conclusion: Valuation Discount Amid Strong Long-Term Performance
The data on Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a meaningful discount to its sector’s P/E ratio despite delivering robust long-term returns. The stock’s recent short-term underperformance and mixed moving average signals suggest some caution, but the medium- and long-term trends remain favourable. The rating update from Buy reflects this balance of valuation and performance factors. Investors may find the valuation gap intriguing given the company’s market leadership and historical growth — what is the current rating for Apollo Hospitals Enterprise Ltd.?
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
